Endometrial Neoplasms Clinical Trials

Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

NCT03564340

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations: University of Alabama_6th Ave Birmingham, Alabama, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber / Harvard Cancer Center Boston, Massachusetts, United States

Mayo Clinic - Rochester Rochester, Minnesota, United States

View all 54 locations

View Trial Details

Recruiting

ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

NCT07270666

Conditions: Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations: Memorial Sloan Kettering Basking Ridge (All Protocol Activites) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) Commack, New York, United States

View Trial Details

Recruiting

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

NCT07198074

Conditions: Advanced Endometrial Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +11 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Alaska Women's Cancer Care Anchorage, Alaska, United States

Cancer Center at Saint Joseph's Phoenix, Arizona, United States

Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States

View all 294 locations

View Trial Details

Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions: Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Bullhead City, Arizona, United States

Research Site Casa Grande, Arizona, United States

Research Site San Diego, California, United States

View all 18 locations

View Trial Details

Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

NCT05256225

Conditions: Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, +17 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Alaska Women's Cancer Care Anchorage, Alaska, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

University of Arizona Cancer Center-North Campus Tucson, Arizona, United States

View all 414 locations

View Trial Details

Recruiting

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

NCT06218914

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +32 more
Locations: Research Site Duarte, California, United States

Research Site Los Angeles, California, United States

Research Site Newport Beach, California, United States

Research Site Jacksonville, Florida, United States

View all 18 locations

View Trial Details

Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06172478

Conditions: Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +70 more
Locations: City of Hope Duarte, California, United States

Yale Cancer Center New Haven, Connecticut, United States

AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States

University of Illinois Cancer Center Chicago, Illinois, United States

View all 91 locations

View Trial Details

Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

NCT05640999

Conditions: Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations: Alaska Womens Cancer Care Anchorage, Alaska, United States

University of Arizona Cancer Center Tucson, Arizona, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

Huntington Memorial Hospital Pasadena, California, United States

View all 122 locations

View Trial Details

Recruiting

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

NCT04590326

Conditions: Adnexal Diseases, Disease Attributes, Endocrine Gland Neoplasms, +25 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

The City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States

Chao Family Comprehensive Cancer Center Orange, California, United States

H. Lee Moffitt Cancer Center Tampa, Florida, United States

View all 28 locations

View Trial Details

Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

NCT05564377

Conditions: Adnexal Diseases, Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, +36 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Alaska Women's Cancer Care Anchorage, Alaska, United States

CTCA at Western Regional Medical Center Goodyear, Arizona, United States

View all 482 locations

View Trial Details

Endometrial Neoplasms

Endometrial Neoplasms trial results

Related conditions